FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3081867701> ?p ?o ?g. }

• W3081867701 abstract "Background: Glioblastoma (GBM) is the most common brain tumor. Despite advancements in multimodal treatment strategies, GBM patients exhibit a dismal prognosis with a median survival of 20 months and a 5-year survival rate post diagnosis of 13%. Standard of care consists of surgical resection, external beam radiation therapy, and adjuvant chemotherapy with temozolomide (TMZ). Despite heavy investment in therapy, GBM patients inevitably experience tumor progression and eventually succumb to their disease. Recently, we showed that lysine-specific histone demethylase 1A (KDM1A), an epigenetic modifier, is overexpressed in GBM. In this study, we tested the hypothesis that KDM1A is essential for DNA damage response (DDR) and inhibition of KDM1A sensitizes GBM to TMZ therapy. Methods: KDM1A knockout (KDM1A-KO) cells were generated using the CRISPR/Cas9 system and knockdown cells were generated using KDM1A specific shRNA (KDM1A-KD). We studied the effect of KDM1A-KO, -KD, or pharmacological KDM1A inhibitors (NCD-38 and NCL-1) on TMZ sensitization using Cell Titer-Glo luminescent cell viability assay, and survival assays. Apoptosis was determined using Caspase 3/7 and TUNEL assays. Mechanistic studies were conducted using RNA-seq, RT-qPCR, and Western blot analysis. Furthermore, the in vivo efficacy of KDM1A inhibitor and TMZ therapy was studied using orthotopic models of GBM using both male and female mice. Results: Cell viability and survival assays demonstrated that knockout/knockdown or inhibition of KDM1A sensitized patient derived glioma stem cells (GSCs) to TMZ treatment. Further, combination of NCD-38 or NCL-1 and TMZ significantly increased the apoptosis of GSCs. RNA-seq analysis revealed the modulation of DDR and apoptotic pathways following combination therapy. Pharmacokinetics (PK) and brain bioavailability studies showed that NCD-38 has favorable PK properties and exhibited a significant penetration through the blood brain barrier. Importantly, combination of NCD-38 and TMZ significantly reduced the in vivo tumor progression and improved the overall survival of both male and female mice compared to single drug treatment in GBM orthotopic models. Conclusions: Our results provide evidence that KDM1A knockdown/inhibition sensitizes GBM to TMZ therapy via modulation of DDR and that the use of KDM1A inhibitor in conjunction with TMZ could serve as a novel therapy for GBM patients. Citation Format: Bridgitte E. Palacios, Prabhakar Pitta Venkata, Yihong Chen, Salvador Alejo, Yi He, Suryavathi Viswanadhapalli, Uday Pratap, Junhao Liu, Xiaonan Li, Takayoshi Suzuki, Siyuan Zheng, Andrew Brenner, Ratna Vadlamudi, Gangadhara Sareddy. KDM1A inhibition sensitizes glioblastoma cells to temozolomide therapy through DNA damage and apoptosis pathway modulation [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 6220." @default.
• W3081867701 created "2020-09-08" @default.
• W3081867701 creator A5005930092 @default.
• W3081867701 creator A5007937560 @default.
• W3081867701 creator A5043867874 @default.
• W3081867701 creator A5044997693 @default.
• W3081867701 creator A5047718399 @default.
• W3081867701 creator A5054728664 @default.
• W3081867701 creator A5060877175 @default.
• W3081867701 creator A5061528278 @default.
• W3081867701 creator A5064393266 @default.
• W3081867701 creator A5071353958 @default.
• W3081867701 creator A5077050764 @default.
• W3081867701 creator A5081874742 @default.
• W3081867701 creator A5083922162 @default.
• W3081867701 creator A5090010000 @default.
• W3081867701 date "2020-08-13" @default.
• W3081867701 modified "2023-10-15" @default.
• W3081867701 title "Abstract 6220: KDM1A inhibition sensitizes glioblastoma cells to temozolomide therapy through DNA damage and apoptosis pathway modulation" @default.
• W3081867701 doi "https://doi.org/10.1158/1538-7445.am2020-6220" @default.
• W3081867701 hasPublicationYear "2020" @default.
• W3081867701 type Work @default.
• W3081867701 sameAs 3081867701 @default.
• W3081867701 citedByCount "0" @default.
• W3081867701 crossrefType "proceedings-article" @default.
• W3081867701 hasAuthorship W3081867701A5005930092 @default.
• W3081867701 hasAuthorship W3081867701A5007937560 @default.
• W3081867701 hasAuthorship W3081867701A5043867874 @default.
• W3081867701 hasAuthorship W3081867701A5044997693 @default.
• W3081867701 hasAuthorship W3081867701A5047718399 @default.
• W3081867701 hasAuthorship W3081867701A5054728664 @default.
• W3081867701 hasAuthorship W3081867701A5060877175 @default.
• W3081867701 hasAuthorship W3081867701A5061528278 @default.
• W3081867701 hasAuthorship W3081867701A5064393266 @default.
• W3081867701 hasAuthorship W3081867701A5071353958 @default.
• W3081867701 hasAuthorship W3081867701A5077050764 @default.
• W3081867701 hasAuthorship W3081867701A5081874742 @default.
• W3081867701 hasAuthorship W3081867701A5083922162 @default.
• W3081867701 hasAuthorship W3081867701A5090010000 @default.
• W3081867701 hasConcept C143425029 @default.
• W3081867701 hasConcept C185592680 @default.
• W3081867701 hasConcept C190283241 @default.
• W3081867701 hasConcept C2776194525 @default.
• W3081867701 hasConcept C2777389519 @default.
• W3081867701 hasConcept C502942594 @default.
• W3081867701 hasConcept C552990157 @default.
• W3081867701 hasConcept C55493867 @default.
• W3081867701 hasConcept C71924100 @default.
• W3081867701 hasConceptScore W3081867701C143425029 @default.
• W3081867701 hasConceptScore W3081867701C185592680 @default.
• W3081867701 hasConceptScore W3081867701C190283241 @default.
• W3081867701 hasConceptScore W3081867701C2776194525 @default.
• W3081867701 hasConceptScore W3081867701C2777389519 @default.
• W3081867701 hasConceptScore W3081867701C502942594 @default.
• W3081867701 hasConceptScore W3081867701C552990157 @default.
• W3081867701 hasConceptScore W3081867701C55493867 @default.
• W3081867701 hasConceptScore W3081867701C71924100 @default.
• W3081867701 hasLocation W30818677011 @default.
• W3081867701 hasOpenAccess W3081867701 @default.
• W3081867701 hasPrimaryLocation W30818677011 @default.
• W3081867701 hasRelatedWork W2012131946 @default.
• W3081867701 hasRelatedWork W2019660019 @default.
• W3081867701 hasRelatedWork W2041270844 @default.
• W3081867701 hasRelatedWork W2144538190 @default.
• W3081867701 hasRelatedWork W2161394680 @default.
• W3081867701 hasRelatedWork W2567075592 @default.
• W3081867701 hasRelatedWork W2590702614 @default.
• W3081867701 hasRelatedWork W2593895879 @default.
• W3081867701 hasRelatedWork W3013584387 @default.
• W3081867701 hasRelatedWork W4319017166 @default.
• W3081867701 isParatext "false" @default.
• W3081867701 isRetracted "false" @default.
• W3081867701 magId "3081867701" @default.
• W3081867701 workType "article" @default.